Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Raw Materials (2018 - 2025)

Jaguar Health (JAGX) has disclosed Raw Materials for 8 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Raw Materials fell 72.44% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 72.44% year-over-year, with the annual reading at $2.0 million for FY2025, 72.44% down from the prior year.
  • Raw Materials for Q4 2025 was $2.0 million at Jaguar Health, up from $2.0 million in the prior quarter.
  • The five-year high for Raw Materials was $7.4 million in Q4 2024, with the low at $701000.0 in Q2 2021.
  • Average Raw Materials over 5 years is $2.0 million, with a median of $2.0 million recorded in 2022.
  • The sharpest move saw Raw Materials surged 260.09% in 2024, then plummeted 72.44% in 2025.
  • Over 5 years, Raw Materials stood at $1.2 million in 2021, then skyrocketed by 68.35% to $2.1 million in 2022, then dropped by 2.09% to $2.1 million in 2023, then soared by 260.09% to $7.4 million in 2024, then tumbled by 72.44% to $2.0 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $2.0 million, $2.0 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.